Ireland
--:--IST
Latest
Clinical Trials in Switzerland / NCT03772548
Recruiting Observational

CNS Changes Following SCI

NCT03772548 · tracked via the Priya Life Science Switzerland tracker
Phase
Observational
Started
2018-07-18
Last updated
2025-12-15

Condition(s) studied

Spinal Cord Injuries

Investigational drug(s) / intervention(s)

MRIMRI

MRI: We will examine acute (\<4 weeks post SCI) to chronic (\>6 months post SCI) patients using functional, structural, and metabolic MRI in both the brain and the spinal cord.

MRI: We will examine healthy control participants using functional, structural, and metabolic MRI in both the brain and the spinal cord.

Study summary

The objective of this study is to better understand the structural and functional changes that the central nervous system (CNS) undergoes following spinal cord injury and how these changes relate to clinical measures. Both macroscopic and microscopic changes of the brain and the spinal cord will be examined in SCI patients and compared to healthy controls. In terms of structural plasticity, we aim to identify MR biomarkers that allow predicting the course of the patient's neurological status and accurately describe the course of the disease and the recovery. Importantly, we aim to investigate which factors scale the patients' symptoms. In terms of functional plasticity, we will combine fMRI with behavioural testing to understand which clinical and behavioural determinants drive functional hand representations in the primary somatosensory and motor cortices to be maintained and which determinants drive reorganisation of functional representations following sensory input loss. We will further investigate the contribution of brainstem reorganisation to plasticity observed at the cortical level and, by doing so, aim to better understand the mechanistic underpinnings of functional reorganisation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria - Patients: * Age 18-75 * Traumatic or non-traumatic spinal cord injury (para- and tetraplegia) * Acute (\<4 weeks post SCI) to chronic SCI (\> 6 months post SCI) * Signed informed consent Exclusion Criteria - Patients: * Contraindications to magnetic resonance imaging * Neurological impairment of body function impairments not induced by spinal cord injury * BMI \> 40 * Pregnancy * Claustrophobia Inclusion Criteria - Healthy subjects: * Age 18-75 * Signed Informed consent Exclusion Criteria - Healthy subjects: * Contraindications to magnetic resonance imaging * Pregnancy * Neurological illness * Impairment of body function induced by a spinal cord injury * Claustrophobia * BMI \> 40

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Universitätsklinik Balgrist Zurich Switzerland Recruiting

More University of Zurich trials in Switzerland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03772548 on ClinicalTrials.gov ↗ ← All trials in Switzerland